Some 2.6 million UK residents have diabetes and this number is rising. These people are at increased risk of heart disease, blindness and limb amputation. It is important to know the difference between Type I and Type II diabetes and how they can be managed to avoid these serious long-term complications. In this special report, you can find recent news and relevant articles about diabetes, including information about the condition and the treatment for it.
For the seventh year running, the National Paediatric Diabetes Audit (NPDA) shows children living with diabetes are being helped to manage their blood glucose levels (HbA1c) and so reduce the risk of developing ...
English Pharmacy Board meeting: 26 January 2017Subscription
The English Pharmacy Board (EPB) met for its first board meeting of the year on 26 January 2017, at the Royal Pharmaceutical Society (RPS)’s London headquarters in Wapping, east London.
Photopharmacology: using light to activate drugsSubscription
Drugs that contain synthetic light-switching molecules could help target therapies to particular parts of the body, limiting side effects. Researchers have started using this approach to tackle blindness, cancer, diabetes, and antibiotic resistance, but questions remain about the clinical practicality of the field.
Building a case on the harm of sugarSubscription
The case against sugar, by Gary Taubes
A US study considers the safety of hormonal contraception with regard to thromoboembolic events for women with diabetes.
The challenges of managing diabetes at mealtimesSubscription
Mealtimes pose many challenges for people living with diabetes, especially those who require a fast-acting insulin treatment to cover the post-meal glucose surge.
Natasha Leeson provides the most popular learning and CPD articles published in The Pharmaceutical Journal and Clinical Pharmacist in 2016.
Non-medical prescribers, including pharmacists, are just as effective at prescribing medicines as medical prescribers, according to the results of a Cochrane Review published on 22 November 2016.
The global spend on medicines is predicted to reach US$1.5 trillion by 2020 — a rise of 33% from 2016 figures, according to a financial forecast by the QuintilesIMS Institute.
An experimental drug originally developed for type 2 diabetes has shown early promise as a treatment for Parkinson’s disease, say researchers who are now planning a clinical trial in humans.
Dextrose gel prevents hypoglycaemia in newbornsSubscription
Study results show that newborns given dextrose gel were less likely to develop hypoglycaemia, but researchers say more research is required in babies from other risk groups.
Addressing men’s health is always an ongoing conundrum and not just limited to “Movember”. Beyond just addressing this health issue, it is also about saving valuable NHS resources, keeping families together for longer, reducing economic loss and improving health equality.
Local practice forum event: 21 SeptemberSubscription